期刊文献+

MicroRNA-29a靶向PTEN/AKT信号通路调节结直肠癌耐药敏感性 被引量:1

MicroRNA-29a regulate resistance to colorectal cancer via targeting on PTEN/AKT signaling pathway
原文传递
导出
摘要 目的探讨MicroRNA-29a(miR-29a)调控结直肠癌细胞HCT-8对化疗药物5-氟尿嘧啶(5-FU)敏感性,以及miR-29a对PTEN蛋白的靶向作用。方法体外培养结直肠癌细胞株HCT-8和5-FU耐药细胞株HCT-8/FU,分别加入适量5-FU,终浓度为0、12.5、25、50、100、200μg/ml的5-FU分别处理HCT-6和HCT-8/FU,培养48h后,用CCK-8法测定,计算IC50;用RT-PCR法检测两株细胞中miR-29a和PTEN的表达情况。耐药细胞株中转染miR-29a inhibitor,CCK-8检测药物敏感性。通过Targetscan网站预测miR-29a的靶基因,并用双荧光素酶报告基因实验验证。shRNA抑制细胞中PTEN的表达,CCK-8法检测不同浓度5-FU作用HCT-8/FU细胞的IC50;Western blot检测敲低miR-29a时,PTEN、AKT及p-AKT蛋白表达变化。结果HCT-8/FU的IC50显著高于HCT-8细胞,miR-29a在HCT-8/FU细胞中表达上调,但PTEN在HCT-8/FU细胞表达下调。miR-29a inhibitor转染HCT-8/FU细胞后,HCT-8/FU细胞的IC50降低。PTEN是miR-29a的靶基因,PTEN表达下调可升高HCT-8/FU细胞IC50,miR-29a抑制物可促进PTEN表达,并抑制p-AKT蛋白水平。结论抑制miR-29a在耐药结直肠癌细胞中的表达可增加细胞对5-FU的药物敏感性,与PTEN/AKT信号通路有关。 Objective To investigate the effect of MicroRNA-29 a(miR-29 a)on the sensitivity of colorectal cancer cell HCT-8 to chemotherapeutic drug 5-fluorouracil(5-FU)and the relationship between miR-29 a and PTEN proteins.Methods The colorectal cancer cell line HCT-8 and 5-FU resistant cell line HCT-8/FU were cultured in vitro.Then appropriate amounts of 5-FU were added to a final concentration of 0,12.5,25,50,100,200 ug/mL of 5-FU for treatment of HCT-6 and HCT-8/FU respectively,and cell activity was measured by CCK-8 after 48 hours cultivation to calculate IC50.The level of miR-29 a and PTEN were detected by RT-PCR in cell lines.Then,miR-29 a inhibitor were transfected into HCT-8/FU cell,and IC50 of HCT-8/FU with miR-29 a inhibitor was detected by CCK-8 assay.The targeting of miR-29 a was predicted through website,targetscan,and verified by double luciferase assay.shRNA was used to inhibit the expression of PTEN,and IC50 was detected.Western blot was used to detect the expression of PTEN,AKT and p-AKT.Results The IC50 of HCT-8/FU was significantly higher than that of HCT-8 cells,miR-29 a was up-regulated and PTEN was down-regulated in HCT-8/FU cells.After miR-29 a inhibitor was transfected into HCT-8/FU cells,the IC50 of HCT-8/FU cells was decreased.3’UTR of PTEN was demonstrated to bind with miR-29 a detected by luciferase assay,down-regulation of PTEN expression increased the IC50 of HCT-8/FU cells,down-regulation of miR-29 a promoted PTEN expression and inhibited the expression of p-AKT.Conclusion Inhibition of miR-29 a in drug-resistant colorectal cancer cells could increase the drug sensitivity of the cells,which is related to PTEN/AKT signaling pathway.
作者 丁红光 张星霖 孙福生 滑晓阳 于辉昌 DING Hong-guang;ZHANG Xing-lin;SUN Fu-sheng;HUA Xiao-yang;YU Hui-rhang(Department of General Surgery(headquarters),Qingdao Ninth People's Hospital,Qingdao 266005,China;Department of Oncology(headquarters),Qingdao Ninth People's Hospital,Qingdao 266005,China;Department of Pharmacy(east hospital),Qingdao Ninth People's Hospital,Qingdao 266005,China;Department of General Surgery,Qingdao Ninth People's Hospital,Qingdao 266005,China)
出处 《解剖科学进展》 2020年第6期645-648,共4页 Progress of Anatomical Sciences
基金 北京市希思科临床肿瘤学研究基金(Y-HR2015-056)。
关键词 小RNA-29a 结直肠癌 5-氟尿嘧啶 耐药 PTEN AKT miR-29a Colorectal cancer 5-fluorouracil drug resistance PTEN AKT
  • 相关文献

参考文献5

二级参考文献37

  • 1Hirofumi Yamamoto,Shingo Noura,Jiro Okami,Mamoru Uemura,Ichiro Takemasa,Masataka Ikeda,Hideshi Ishii,Mitsugu Sekimoto,Nariaki Matsuura,Morito Monden,Masaki Mori.Overexpression of MT1-MMP is insufficient to increase experimental livermetastasis of human colon cancer cells[J]. International Journal of Molecular Medicine . 2008 (6)
  • 2Astrid E. Greijer,Pien M. Delis-van Diemen,Remond J. A. Fijneman,Rachel H. Giles,Emile E. Voest,Victor W. M. Hinsbergh,Gerrit A. Meijer.Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum[J]. Virchows Archiv . 2008 (5)
  • 3Gregg L Semenza.HIF-1: upstream and downstream of cancer metabolism[J]. Current Opinion in Genetics & Development . 2009 (1)
  • 4Stine Aske Danielsen,Peter Wold Eide,Arild Nesbakken,Tormod Guren,Edward Leithe,Ragnhild A. Lothe.Portrait of the PI3K/AKT-pathway in colorectal cancer[J]. BBA - Reviews on Cancer . 2014
  • 5Carol E. DeSantis,Chun Chieh Lin,Angela B. Mariotto,Rebecca L. Siegel,Kevin D. Stein,Joan L. Kramer,Rick Alteri,Anthony S. Robbins,Ahmedin Jemal.Cancer treatment and survivorship statistics, 2014[J]. CA: A Cancer Journal for Clinicians . 2014 (4)
  • 6Xiao ZM,Wang XY,Wang AM.Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway. Biotechnology and Applied Biochemistry . 2015
  • 7Yukihiro Akao,Shunsuke Noguchi,Akio Iio,Keitaro Kojima,Takeshi Takagi,Tomoki Naoe.??Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells(J)Cancer Letters . 2010
  • 8M Moschetta,A Reale,C Marasco,A Vacca,M R Carratù.??Therapeutic targeting of the mTOR ‐signalling pathway in cancer: benefits and limitations(J)Br J Pharmacol . 2014 (16)
  • 9Liao Chiung-Ho,Sang Shengmin,Ho Chi-Tang,Lin Jen-Kun.Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through down-regulation of Src, ERK, and Akt survival signaling in human colon cancer cells. Journal of cellular biochemistry . 2005
  • 10Liu Guangming,Hu Xin,Varani James,Chakrabarty Subhas.Calcium and calcium sensing receptor modulates the expression of thymidylate synthase, NAD(P)H:quinone oxidoreductase 1 and survivin in human colon carcinoma cells: promotion of cytotoxic response to mitomycin C and fluorouracil. Molecular Carcinogenesis . 2008

共引文献24

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部